The second supplementary scheme booklet goes a long way to clarify many of the issues. It is a pity that TWO supplementary booklets were required. The board is at last on record as stating that ResApp is viable without Pfizer. I have learned far more from reading the Court decisions than I have from information provided by the BOD. I am looking forward to studying the decisions of 23 Aug and 25 Aug, when published, and to which I will provide links on the appropriate thread.
- Forums
- ASX - By Stock
- RAP
- Ann: Second Supplementary Scheme Booklet
Ann: Second Supplementary Scheme Booklet, page-58
-
-
- There are more pages in this discussion • 198 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online